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Retinoids synergize with insulin to induce hepatic Gck expression
Guoxun CHEN*1, Yan ZHANG*, Danhong LU†, Nan-qian LI‡ and A. Catharine ROSS‡
*Department of Nutrition, UTK (University of Tennessee at Knoxville), Knoxville, TN 37996, U.S.A., †Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical
Center, Durham, NC 27704, U.S.A., and ‡Department of Nutritional Sciences, Pennsylvania State University, University Park, PA 16802, U.S.A.
Hepatic GK (glucokinase) plays a key role in maintaining glucose
homoeostasis. Many stimuli regulate GK activity by controlling
its gene transcription. We hypothesized that endogenous lipo-
philic molecules modulate hepatic Gck expression. Lipophilic
molecules were extracted from rat livers, saponified and re-con-
stituted as an LE (lipophilic extract). LE synergized with insulin
to induce primary hepatocyte, but not β-cell, Gck expression
in an SREBP-1c (sterol-regulatory-element-binding protein-1c)-
independent manner. The dramatic induction of Gck mRNA
resulted in a significant increase in GK activity. Subsequently,
the active molecules were identified as retinol and retinal by
MS after the purification of the active LE fractions. Retinoids
synergized with insulin to induce Gck expression by the activation
of both RAR [RA (retinoic acid) receptor] and RXR (retinoid
X receptor). Inhibition of RAR activation completely abolished
the effect of retinal. The hepatic GK specific activity and Gck
mRNA levels of Zucker lean rats fed with a VAD [VA (vitamin
A)-deficient] diet were significantly lower than those of rats
fed with VAS (VA-sufficient) diet. Additionally, the hepatic Gck
mRNA expression of Sprague–Dawley rats fed with a VAD diet
was lower than that of rats fed with VA-marginal, -adequate
or -supplemented diets. The reduced expression of Gck mRNA
was increased after an intraperitoneal dose of RA in VAD rats.
Furthermore, an intravenous injection of RA rapidly raised hepatic
Gck expression in rats fed with a VAS control diet. Understanding
the underlying mechanism that mediates the synergy may be
helpful for developing a treatment strategy for patients with
diabetes.
Key words: hepatic glucokinase gene expression, insulin, primary
hepatocyte, retinoid, synergistic effect, vitamin A deficiency.
INTRODUCTION
Glucose must first be phosphorylated before being utilized by
cells. This reaction is catalysed by a family of enzymes called
hexokinases, which are found in different organisms ranging
from bacteria to humans [1]. Mammalian hexokinase IV (D),
also known as GK (glucokinase) (ATP:D-hexose 6-phosphotrans-
ferase; EC 2.7.1.1), plays a key role in maintaining glucose homo-
eostasis [2]. GK mutations have been associated with maturity
onset diabetes of the young [3]. Whole-body or tissue-specific
deletion of Gck in rodents demonstrated that either pancreatic
β-cell or hepatic GK activity is essential for glucose homoeostasis
[4,5].
As an essential micronutrient, VA (vitamin A; retinol) plays
crucial roles in the general health of an individual [6]. Therefore
retinol homoeostasis must be delicately maintained to meet opti-
mal physiological requirements. This homoeostasis is achieved
by a network of enzymes and proteins involved in the transport,
production and catabolism of retinoids [7]. The regulation of
this system can be attributed to the control of the expression
of some of these enzymes by the active metabolite of retinol, RA
(retinoic acid) [8]. RA exists in multiple isomeric forms, such
as all-trans RA and 9-cis-RA, and RA regulates gene expression
through activation of two families of nuclear receptors, RARs
(RA receptors; RARα, β and γ ) activated by all-trans RA and
RXRs (retinoid X receptors; RXRα, β and γ ) activated only by
9-cis-RA [9]. Elevation of hepatic VA contents in patients with
diabetes was observed more than 70 years ago (in 1937) [10].
Depletion of hepatic glycogen content in VAD (VA-deficient) rats
was reported in 1957 [11].
Long-term regulation of hepatic GK activity is controlled by its
mRNA level. Transcription of Gck is regulated differentially by
an upstream promoter in pancreatic β-cells and a downstream
promoter in hepatocytes [12,13]. Activation of either one of
them leads to the generation of a Gck mRNA with distinct 5′
sequences derived from the tissue-specific first exon. In rat liver,
Gck mRNA is induced by insulin and suppressed by glucagon,
a counter regulatory hormone to the actions of insulin [14,15].
It has been reported that RA induced Gck expression in rat
hepatocytes without any additive effects on insulin-mediated
induction [16,17].
Insulin resistance, diabetes and other metabolic abnormalities
are associated with profound changes in hepatic lipid and glucose
metabolism. These can be attributed to the altered expression
of insulin-responsive genes [18]. Insulin-responsive elements in
the Srebp-1c promoter have been identified as two LXR (liver X
receptor)-binding sites and one sterol-regulatory element [19].
This implies that insulin could regulate the expression of its
responsive genes by stimulation of the synthesis of endogenous
agonists for nuclear receptor activation. We hypothesized that
endogenous lipophilic molecules may play a role in the expression
of genes involved in glucose metabolism. Herein, we report that
an LE from rat liver synergized with insulin to induce hepatocyte
Gck expression in an SREBP-1c (sterol-regulatory-element-
binding protein-1c)-independent manner. The active molecules
were subsequently identified as retinol and retinal. Retinoids
Abbreviations used: Ct, threshold cycle value; GK, glucokinase; IU, international unit; LE, lipophilic extract; LXR, liver X receptor; mmu, milli mass unit;
RA, retinoic acid; RAL, all-trans-retinal; RAR, RA receptor; ROL, all-trans-retinol; RXR, retinoid X receptor; SREBP-1c, sterol-regulatory-element-binding
protein-1c; TTNPB {(E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethylnaphthyl-2-enyl)propen-1-yl]benzoic acid}; VA, vitamin A; VA-Ad, VA-adequate; VAD
diet, VA-deficient diet; VAM, VA-marginal; VAS diet, VA-sufficient diet; VA-Sup, VA-supplemented.
1 To whom any correspondence should be addressed, at 229 Jessie Harris Building, 1215 West Cumberland Avenue, Knoxville, TN 37996, U.S.A.
(email gchen6@utk.edu).
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The reagents for primary hepatocyte isolation and culture have
been published earlier [20]. GK activity assay reagents were
obtained from Fisher Scientific (Pittsburgh, PA, U.S.A.). Ro41-
5253 was obtained from Biomol (Plymouth Meeting, PA, U.S.A.).
T0101317 was from J-Star Research (South Plainfield, NJ,
U.S.A.). LG268 was synthesized in the core facility at the
University of Texas Southwestern Medical Center at Dallas. All
other compounds were purchased from Sigma (St. Louis, MO,
U.S.A.) unless described otherwise.
Animals
Sprague–Dawley rats (for hepatocytes) and Wistar rats (for islets)
were purchased from Harlan Breeders (Indianapolis, IN, U.S.A.).
Zucker lean rats (fa/+, for diet study) were bred at UTK. Rats
were housed in colony cages, and fed with a standard rodent diet.
All procedures were approved by the Institutional Animal Care
and Use Committee at the UTK, Pennsylvania State University or
Duke University Medical Center.
Pancreatic islets, INS-1 cells and primary hepatocytes
Islets were harvested using Liberase R1 enzyme (Roche
Diagnostics, Indianapolis, IN, U.S.A.) as described in [21].
Approximately 100 islets per treatment were incubated in 2 ml
of RPMI 1640 medium containing 10% (v/v) fetal calf serum
in the absence or presence of LE (80 μg/ml) for 6 h. INS-1 cells
were maintained as described previously [22]. Cells at 2 × 106 per
60 mm plate were treated without or with LE (80 μg/ml) in 2 ml of
serum-free RPMI 1640 for 6 h. Primary hepatocytes were isolated
and they were cultured as previously described [20]. All the tissue
culture procedures were performed under yellow light.
RNA extraction and quantitative real-time PCR
Methods for preparation and analysis of RNA were described
previously [20]. The real-time PCR primer sets for detecting Gck
[23], Cyp26a1 [24] and Ubc [25] cDNAs have been reported
previously. The primer sequences for Srebp-1c, 5′-GGAGCCA-
TGGATTGCACATT-3′ (forward) and 5′-AGGCCAGGGAAGT-
CACTGTCT-3′ (reverse), were designed using Primer Express
software (Applied Biosystems). The gene expression level was
normalized to that of the control housekeeping gene 36B4
unless described otherwise. Results are presented as fold
induction for which the control group is arbitrarily assigned
a value of 1, or the difference of the Ct (threshold cycle value)
between the experimental gene and the control gene (36B4).
GK specific activity assay
For hepatocytes, cells at 3 × 106 per 60 mm plate were incubated
in a medium containing the vehicle control, LE (80 μg/ml), insulin
(1 nM) and insulin + LE for 9 h. Plates were washed once with
cold PBS, frozen in liquid nitrogen and stored at −80 ◦C before
GK activity assay [26]. For liver tissue of rats fed with VAD
and VAS (VA-sufficient) diets, GK activity was measured by a
discontinuous assay as described in [27]. Glucose-phosphoryl-
ating activity was measured spectrophotometrically in the pres-
ence of 0.5 mM glucose (considered as hexokinase activity) and
30 mM glucose (total activity). The activity obtained by subtract-
ing the activity measured at 0.5 mM glucose from the total activity
measured at 30 mM glucose was considered the GK activity. One
unit is defined as activity that phosphorylates 1 μmol of D-
glucose to D-glucose 6-phosphate per min. GK specific activity is
presented as m-units/mg of protein of cell or tissue lysate.
Separation and extraction of LE components for activity assay
The LE preparation method has been published earlier [20].
Approx. 0.4 mg of LE was spotted on 1/8 of a silica gel TLC plate.
The rest of the plate was spotted with 8 mg of LE in a continuous
line. The plate was developed with ethyl ether/toluene (1:2, v/v)
for 1 h. The 1/8 portion was cut and stained in iodine vapour. The
lipid bands were marked, and the whole TLC plate was divided
into 12 fractions from bottom to top. The corresponding bands
were scraped from the plate and extracted twice with 10 ml of
15% acetyl acetate in hexane. Then 1 ml of each fraction was
combined and named the ‘mixed fraction’, which theoretically
contains 5% of the input. All fractions were dried under
nitrogen, weighed and reconstituted in 150 μl of ethanol, except
for the mixed fraction, which was reconstituted in 20 μl of
ethanol, a 2-fold dilution compared with the input. The purity
of the reconstituted fractions was confirmed using TLC and the
same development condition. After development, the plate was
visualized with iodine vapour and the image was scanned with
an HP ScanJet5300C scanner. The fractions and the input were
tested for their effects on Gck expression using real-time PCR.
MS analysis
Fractions with LE activity, and standards of retinol, retinal and
cholesterol were dissolved in anhydrous ethanol and applied
directly on to a Jeol AccuTOF-DARTTM mass spectrometer in the
MS core facility at the UTK. Positive mode was used. To identify
each peak, natural abundance of isotope was assumed and used to
deduce the molecular formula of each monoisotopic peak. The
possible molecular formula of each peak was predicted by
the software of the MS system with an allowed m/z error of less
than 2 mmu (milli mass units). The spectral patterns of fragment
ions derived from retinol, retinal and cholesterol were predicted
by the software with the MS system, and confirmed using
commercially available standards run under the same conditions.
Dietary studies and RA treatments in vivo
For dietary studies, female Sprague–Dawley rats (Charles River,
Wilmington, MA, U.S.A.) were fed with a semisynthetic diet
(AIN-93G diet, prepared for us by Research Diets, New Brun-
swick, NJ, U.S.A.), containing one of four levels of VA. The diets,
designated VAD, VAM (VA-marginal), VA-Ad (VA-adequate)
and VA-Sup (VA-supplemented) (0, 0.4, 4 and 100 mg of retinol
equivalents per kg of diet respectively) were fed continuously
from weaning to 8 weeks of age [28]. For the four diet groups,
there were no differences in body weight, and body condition
was indistinguishable. The VAD groups had significantly lower
plasma retinol, 0.09 μM, compared with 0.9–1.4 μM in the other
three groups.
For liver GK activity study, male Zucker lean rats (fa/+, four
rats per group) were fed with a VAD purified diet (no. 5822; 0
IU (international unit)/g VA; TestDiet, Richmond, IN, U.S.A.) or
a basal diet (no. 5755; 22.1 IU/g VA; TestDiet). The diets were
fed continuously from weaning to 9 weeks of age. At this time,
the body weight gain of rats fed with VAD diet stopped due to
c© The Authors Journal compilation c© 2009 Biochemical Society
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VA deficiency [29]. Animals were fasted for 6 h before they were
killed for analysis of hepatic Gck expression and GK activity.
Two studies of the acute response to RA were conducted. In
the first study, a 16 h time course in VAD rats, rats fed with the
VAD diet as described above, were treated once with 100 μg of
RA, delivered intraperitoneally for rapid uptake [24]. After 0 h
(placebo treatment) and 3, 6, 10 and 16 h of RA treatment, the
rats were individually killed and liver was collected for analysis.
A second, short-term 90 min experiment was conducted in which
rats of the same strain and sex, purchased at 6 weeks of age, were
fed with a stock rodent diet until 8 weeks of age, at which time they
received a single injection of albumin-bound RA administered
into the common iliac vein, leading to rapid hepatic uptake [30].
The RA dose equalled ∼25 μg per rat (10 μg/100 g body weight),
and liver was collected after 0 h (vehicle injection), and 0.5, 1 and
1.5 h after injection of RA, as described above.
Statistics
Results are presented as means +− S.D. The number of experiments
represents the independent experiments using hepatocytes
isolated from different animals on different days. A Levene’s
test was used to determined homogeneity of variance among
groups using SPSS 16.0 statistical software, and where necessary,
natural log transformation was performed before analysis. An
independent-samples Student’s t test was used to compare two
conditions. Multiple comparisons were analysed by one-way
ANOVA using LSD (least significant difference) or Tukey’s test
(for Figures 8 and 9 only due to unequal sample numbers in dif-
ferent groups) when equal variance was assumed, and the Games–
Howell test was used when equal variance was not assumed.
Differences were considered statistically significant at P < 0.05.
RESULTS
LE synergized with insulin to induce Gck expression in primary
hepatocytes
LE and insulin alone increased the expression of Gck mRNA by
7.6 +− 5.9- and 19.3 +− 12.4-fold respectively (Figure 1A). LE +
insulin induced Gck expression by 155 +− 72-fold, which is much
higher than the sum of the individual effects of LE and insulin
(7.6 + 19.3 = 26.9), demonstrating a synergy between LE and
insulin. The induction occurred at a physiological concentration
of glucose (5 mM in the culture medium), suggesting the
physiological relevance of the observation.
It is possible that LE lowers the concentration required to reach
a maximal fold induction by insulin. To test this, hepatocytes
were treated without or with LE in the presence of increasing
concentrations of insulin (from 0 to 100 nM). Figure 1(B) shows
that the Gck expression increased from 1 (0 nM insulin) to 16-fold
without LE and increased from 7- to 139-fold with LE. The
induction by insulin reached the maximum (16.3-fold) at 10 nM
insulin. The synergy between LE and insulin was evident at all
concentrations of insulin tested. The fold induction by LE +
insulin was beyond that which could be achieved by insulin
alone. This result indicated that LE synergizes with insulin, rather
than sensitizing the cells to an insulin-mediated transcriptional
response.
LE had no effects on Gck expression in pancreatic β-cells,
whereas LE + insulin induced GK activity in primary hepatocytes
Alternative promoters are used for tissue-specific Gck expression
in hepatocytes and pancreatic β-cells [13]. As the primer set for
Figure 1 LE synergizes with insulin to induce Gck expression in rat liver
hepatocytes
(A) The synergistic effect at 1 nM insulin (mean +− S.D., n = 7 with four batches of LE
preparation, all *P < 0.001). (B) The synergistic effect of LE at increasing concentrations
of insulin (means +− S.D., n = 3, all *P < 0.02 for comparing the control group with the LE
group at the corresponding insulin concentration). Hepatocytes were treated with indicated
concentrations of insulin in the absence or presence of LE for 6 h. The Gck mRNA expression
level in the vehicle control group was arbitrarily assigned a value of 1.
Figure 2 Effects of LE on the expression of Gck mRNA in rat islets and
pancreatic β-cells and on GK activity in primary hepatocytes
(A) Gck transcript levels in insulin-secreting cells. The level of Gck mRNA for each cell type in
the vehicle control group was arbitrarily assigned a value of 1 (mean +− S.D., n = 3). (B) GK
activity in primary hepatocytes treated without or with LE in the absence or presence of 1 nM
insulin for 9 h. GK specific activity was measured as described in the Materials and methods
section (mean +− S.D., n = 3, all *P < 0.02 for comparing LE + insulin with the vehicle control,
LE or insulin group respectively).
real-time PCR detects both β-cell and hepatocyte Gck cDNA, the
Gck expression in rat islets and two clones of INS-1 cells were
examined. There was no significant induction of Gck mRNA
in islets, 833/15 and 833/117 INS-1 cells after LE treatment
(Figure 2A). These results indicate that the LE effect is specific
to hepatocytes.
GK activity in hepatocyte cell lysates was measured (Fig-
ure 2B). LE alone did not change GK activity, whereas GK activ-
ity in the LE + insulin group was significantly higher than that
in the vehicle, insulin alone and LE alone groups. Thus, although
the increase in GK activity was less than that for Gck mRNA,
there was a significant induction of GK activity after LE + insulin
treatment.
LE did not affect the decay of Gck mRNA in primary hepatocytes
Experiments were designed to measure the effect of LE on the
decay of Gck mRNA (Figure 3A). Hepatocytes were treated with
vehicle or LE in the absence or presence of 1 nM insulin for
c© The Authors Journal compilation c© 2009 Biochemical Society
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Figure 3 LE does not regulate the decay of Gck mRNA in rat liver
hepatocytes
(A) Schematic diagram of the experimental design. Hepatocytes were treated with or without
80 μg/ml of LE in the absence or presence of 1 nM insulin for 6 h. One set of dishes was treated
with LE + insulin and washed once with PBS and then incubated in a fresh medium containing
3 μM α-amanitin in the absence and presence of LE. Total RNA was isolated at 0.5, 1, 2, 4
and 6 h after the treatment and subjected to real-time PCR analysis. (B) Synergism of LE with
insulin on Gck expression (all *P < 0.002). (C) Stability of 36B4 transcripts. (D) Stability of
Gck transcripts. The level of each transcript at zero time was arbitrarily assigned a value
of 100 % (mean +− S.D., n = 4).
6 h. A set of dishes treated with LE + insulin for 6 h was washed
once with PBS and then incubated in a medium containing 3 μM
α-amanitin, a specific inhibitor of RNA polymerase II complex
[31], without or with LE. Levels of 36B4 and Gck transcripts
at the indicated time points were determined by real-time PCR
analysis. LE synergized with insulin to increase Gck mRNA, as
anticipated (Figure 3B). The decay of 36B4 mRNA (an invariable
control gene) was not affected by LE treatment (Figure 3C). The
estimated half-life of 36B4 mRNA was more than 6 h for either
vehicle or LE group. The decay rate of Gck mRNA was similar
in the absence or presence of LE (Figure 3D). The levels of Gck
mRNA decreased rapidly after the removal of insulin and the
initiation of transcription inhibition by α-amanitin. The estimated
half-life of Gck mRNA for either group was approx. 45 min, which
agrees well with published results [14]. These results demonstrate
that LE does not affect the rate of decay of Gck mRNA.
The induction of Gck expression by LE + insulin occurred in an
Srebp-1c induction-independent manner
Since SREBP-1c, an insulin-induced transcription factor, has
been suggested to be the main mediator of insulin-induced Gck
expression [32], an induction of Srebp-1c expression would be
anticipated if it also mediates the action of LE. The expression of
Gck (Figure 4A) and Srebp-1c (Figure 4B) was monitored over a
24 h period of time after the indicated treatments. The Gck mRNA
levels in the control group (a value of 1 at zero time) decreased
significantly to 0.2 +− 0.04 in 3 h and further declined up to 24 h.
The Gck mRNA levels in the LE group were significantly higher
than those in the control group at each of the corresponding time
Figure 4 Comparison of the expression levels of Gck (A) and Srebp-1c
(B) mRNA over time and the effect of LXR activation on Gck (C) and
Srebp-1c (D) expression in hepatocytes
(A, B) Hepatocytes were treated with or without LE in the absence or presence of 1 nM insulin. The
expression level of indicated transcripts at zero time was assigned a value of 1 (mean +− S.D.,
n = 3, all *P < 0.02 for comparing the vehicle control and LE groups at 3, 6, 9 and 12 h
respectively; all **P < 0.02 for comparing insulin with the LE + insulin groups at 3, 6, 9 and
12 h respectively; all ***P < 0.02 for comparing insulin with the LE + insulin groups at 3
and 6 h respectively). (C, D) Hepatocytes were treated without or with 1 μM T0901317 in the
absence or presence of 1 nM insulin for 6 h. The level of indicated transcripts in the vehicle
control group was arbitrarily assigned a value of 1 (mean +− S.D., n = 3, all *P < 0.001).
points. The reduction in Gck mRNA occurred in both groups and
stabilized after 6 h of incubation. Treatment with insulin alone
resulted in only a small increase in Gck mRNA at 3 h, compared
with its level at zero time. The Gck mRNA levels in the LE +
insulin group were significantly higher than those in the insulin
group at each of the 3, 6, 9 and 12 h time points. The synergy
between insulin and LE was evident as early as 3 h. Thus the
presence of LE maintained hepatocyte Gck mRNA at a signific-
antly higher level, regardless of the presence or absence of insulin.
In the same study, Srebp-1c mRNA in both the control group
and the LE group decreased at the same rate and stabilized after
6 h without insulin (Figure 4B). A comparison of Figures 4(B) and
4(A) shows that the induction pattern of Srebp-1c mRNA does not
match that of Gck mRNA. First, LE only transiently synergized
with insulin to induce the expression of Srebp-1c mRNA at
3 and 6 h. Secondly, the peaks in Gck mRNA induced by insulin
and LE + insulin treatments preceded those of Srebp-1c mRNA
induced by the same treatments. Moreover, Gck mRNA in the
LE + insulin group had already started to decline when the Srebp-
1c mRNA began to reach a peak at 9–12 h. These results suggest
that the effect of LE could be SREBP-1c independent, which was
further examined next.
The expression of Srebp-1c can be specifically induced by
treatment with T0901317, a non-sterol agonist for LXR activation
[33]. Treatments with T0901317, insulin and T0901317 + insulin
induced Gck mRNA levels by 1.4 +− 0.3-, 12 +− 2.5- and 18 +− 1.6-
fold respectively, whereas T0901317 alone did not significantly
induce Gck expression (Figure 4C). Although the induction by
T0901317 + insulin was significantly higher than that produced
by insulin alone (P < 0.05), the difference between them (1.5-fold,
18 versus 12) was not comparable with the difference between
c© The Authors Journal compilation c© 2009 Biochemical Society
Retinoids synergize with insulin 649
Figure 5 Fractionation and characterization of the components of LE
(A) Separation of LE on a silica gel TLC plate. The detailed procedure is described in the Materials and methods section. The boundaries of fractions F1–12 are marked. (B) Separation of retinoid
standards, LE and reconstituted fractions on a TLC plate, from left to right: lane 1, ROL (28.7 μg); lane 2, RAL (28.4 μg); lane 3, RA (15 μg); lane 4, LE (200 μg); lanes 5–16, 1:15 (v/v) of each
fraction from fractions F1–F12. (C) The effects of each fraction on Gck expression. Hepatocytes were treated with the vehicle control, LE input, equivalent amounts of fractions F1–F12 or the
mixed fraction in the presence of 1 nM insulin for 6 h. The level of Gck mRNA in the control group was arbitrarily assigned a value of 1. (D) Positive m/z spectrum of fraction F5 obtained by a Jeol
AccuTOF-DARTTM mass spectrometer. The allowed m/z error was less than 2 mmu. Natural abundance of isotope was assumed and used for deducing the molecular formula of each monoisotopic
peak (* indicates unknown and ** indicates cholesterol).
LE + insulin and LE treatments (8-fold, 155 versus 19, shown
previously in Figure 1A). This comparison demonstrates that
T0901317 and insulin did not synergize to increase Gck
expression. However, T0901317, insulin and T091317 + insulin
all induced Srebp-1c mRNA significantly (Figure 4D). Moreover,
T0901317 synergized with insulin, demonstrating a robust
response of Srebp-1c expression to LXR activation. These results
thus indicate that the massive induction of Srebp-1c expression
by T0901317 or T0901317 + insulin is not sufficient to mimic the
LE or LE + insulin effects on Gck expression.
Retinol and retinal were identified as the active molecules
present in LE
To identify the active molecules present in LE, it was first sepa-
rated on a TLC plate into eight detectable lipid bands (Figure 5A),
after which the whole TLC plate from the origin to solvent front
was divided into 12 fractions and each was extracted to obtain
the components of them. Figure 5(B) shows an image of the
TLC plate after running authentic standards of ROL (all-trans-
retinol; 28.7 μg), RAL (all-trans-retinal; 28.4 μg), all-trans-RA
c© The Authors Journal compilation c© 2009 Biochemical Society
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Figure 6 Retinoids synergize with insulin to induce Gck mRNA expression in rat primary hepatocytes
Hepatocytes were treated with the vehicle control or increasing concentrations of ROL, RAL and RA in the absence or presence of 1 nM insulin for 6 h. Gck mRNA level in the vehicle control group
was assigned a value of 1 (mean +− S.D., n = 3, a < b, c < d, all P < 0.05).
Figure 7 Effects of RAR/RXR activation (A) or inhibition of RARα (B) on the expression of Gck mRNA
(A) Hepatocytes were incubated in media containing the vehicle control, TTNPB (RAR pan-agonist; 1 μM), LG268 (RXR agonist; 1 μM) or TTNPB + LG268 in the absence and presence of 1 nM
insulin (mean +− S.D., n = 3, a < b < c < d, e < f < g, all P < 0.03). (B) Hepatocytes were treated with indicated concentrations of Ro41-5253, an RAR antagonist, without or with 2 μM RAL in
the presence or absence of 1 nM insulin (mean +− S.D., n = 3, a ′ < b ′ , c ′ < d ′ < e ′, all P < 0.03). The expression level of Gck mRNA in the vehicle control group was assigned a value of 1.
(Figure 5B, ‘RA’; 15 μg), along with LE (200 μg) and 1/15 of
each of the reconstituted fractions. Fraction F5 had the same
mobility as retinol in this TLC system. The effects of each fraction
on Gck mRNA expression were measured (Figure 5C). When the
Gck expression level in hepatocytes treated with insulin alone
was assigned a value of 1 (control), the input, F5, F6, F7 and
the mixed fraction with equivalent amounts to the input resulted
in a further induction of Gck expression by 5.3-, 2.3-, 1.3-, 1.7-
and 2.1-fold respectively. Although part of the LE activity in the
input was apparently lost, as the fold induction by each active
fraction was lower than the fold induction by the un-separated
input, nevertheless the fold induction of Gck mRNA by the mixed
fraction was the same as for fraction F5. This demonstrated that
there were no additive effects when the components of all the
fractions were combined. Since F5 appeared as a single band,
it was subjected to MS analysis for identification. Figure 5(D)
shows the positive m/z spectrum of F5. The m/z values of the
indicated monoisotopic peaks matched the theoretical m/z values
of the fragment ions for retinol, retinal and cholesterol, with
errors of less than 2 mmu. The existence of these monoisotopic
peaks was confirmed.
Since cholesterol has no effect on Gck expression (results not
shown), we analysed the effects of ROL, RAL and RA (Figure 6).
Without insulin, a significant induction of Gck expression was
detected at 2 μM of ROL, 0.2 μM of RAL and 0.002 μM of RA.
When insulin was present there was a 14.2 +− 1.7-fold increase
with insulin alone, and the synergy of insulin plus retinoids began
to be evident at the same concentrations at which the retinoids
alone were effective. The overall sequence of potency, from
the weakest to the strongest inducer, was ROL < RAL < RA.
Thus, although all three retinoids induced Gck expression and
synergized with insulin at 2 μM or higher, only RA synergized
with insulin at concentrations as low as 0.002 μM. These results
demonstrated that although several retinoids added to hepatocytes
synergize with insulin to induce Gck expression, RA is the most
potent by several orders of magnitude.
Activation of both RAR and RXR mimicked and inhibition of RARα
activation abolished the synergy between retinoids and insulin
on Gck expression
As retinoids are known to activate RAR and RXR, primary hepato-
cytes were treated with TTNPB {(E)-4-[2-(5,6,7,8-tetrahydro-
5,5,8,8-tetramethylnaphthyl-2-enyl)propen-1-yl]benzoic acid}
(1 μM), a specific panagonist of RARs, and LG268 (1 μM), an
RXR-specific agonist. Activation of RAR alone or RXR alone
was sufficient to significantly induce Gck expression without
or with insulin (Figure 7A). Additionally, a robust synergy
with insulin was evident for both agonists. The fold induction
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Figure 8 The hepatic Gck mRNA (A) and GK enzyme activity (B) in livers of
Zucker lean rats fed with VAS and VAD diets and the Gck mRNA in livers
of Sprague–Dawley rats in steady state (C) and after treatment of VAD rats
with RA administered intraperitoneally (D)
(A, B) Zucker lean rats were fed with VAD and VAS diet for 9 weeks. (C) Different categories of
VA status were produced by feeding rats with one of four diets: VAD, VAM, VA-Ad and VA-Sup.
(D) VAD rats received a single intraperitoneal administration of 100 μg of RA. Individual VAD
rat livers were collected for analysis at the indicated time points. The results are presented as
−Ct [–Ct = (Ct of 36B4) − (Ct of Gck )] for mRNA and m-units/mg of GK enzyme activity.
Total RNA was isolated from individual rat livers (a > b; c > e, f ; and d > f , all P < 0.02).
Animal number, n, per group is shown in parentheses.
were comparable with those induced by 20 μM of RAL or RA
(comparing Figures 7A with Figure 6), indicating that retinoids
synergize with insulin by activation of both RAR and RXR.
If this conclusion is true, it may be possible to blunt the
synergy using an antagonist of RAR activation. Figure 7(B) shows
Gck mRNA levels in hepatocytes treated with RAL and insulin
in the presence of increasing concentrations of Ro41-5253, a
specific antagonist of RARα activation [34]. When RAL was
not added, Ro41-5253 did not cause any significant reduction
in Gck expression in the absence or presence of insulin. When
insulin was absent, the fold induction of Gck expression by 2 μM
RAL (3.7 +− 1.2-fold) was completely abolished (1.1 +− 0.3-fold)
by 10 μM Ro41-5253. The synergy between 2 μM RAL and
insulin (46.1 +− 11.8-fold) was completely abolished (9.4 +− 3.4-
fold) by 10 μM Ro41-5253. These results imply that activation
of RARα is required for the synergistic effects of retinoids and
insulin.
VA deficiency resulted in a reduction in hepatic Gck expression
and GK activity
To examine the physiological significance of the observation
obtained with hepatocytes, GK specific activity and Gck mRNA
levels in the livers of Zucker lean rats fed with VAD and VAS
diets were measured. Expression of Gck mRNA was assessed by
real-time PCR analysis and expressed as the negative difference
of the Ct [−Ct = (Ct of 36B4) − (Ct of Gck)]. The larger the
−Ct, the higher the expression level of the indicated transcripts.
As shown in Figure 8(A), the Gck mRNA levels in the livers of
rats fed with a VAD diet were significantly lower than those in the
livers of rats fed with a VAS diet. This reduction of Gck mRNA
correlates with a significant decrease in GK specific activity in
livers of VAD rats (Figure 8B). The hepatic GK activity of VAD
rats is significantly lower than that of VAS rats (11.3 +− 1.6 versus
19.5 +− 2.1 m-units/mg respectively).
To further confirm the observation, we also measured Gck
expression in livers of Sprague–Dawley rats fed with four diets
with different levels of VA, denoted by VAD, VAM, VA-Ad and
VA-Sup diets. The levels of Gck mRNA in the liver of VAD rats
were significantly lower than those in VAM, VA-Ad or VA-Sup
diet groups (Figure 8C). These results demonstrated that a lack
of retinoids due to VA deficiency results in a reduction in hepatic
Gck expression.
RA treatment induced Gck expression in livers of VAD rats
Since RA was more potent in inducing hepatocyte Gck expression,
and is the transcriptionally active metabolite of dietary VA [35],
we next examined its effect on hepatic Gck expression in VAD
rats. The Gck mRNA (Figure 8D) was measured at 0, 3, 6, 10
and 16 h after a single intraperitoneal dose of 100 μg of RA.
The Gck expression was significantly induced as early as 3 h and
remained significantly higher for at least 10 h before returning
to the basal level 16 h later. These kinetics agreed with the
effects of LE on Gck expression in hepatocytes (Figure 3A), in
which Gck mRNA reached a peak at 3 h and fell back to basal
level at 24 h after LE. This in vivo experiment thus indicated
that RA is sufficient for inducing Gck expression in the liver
of VAD rats. The results also suggest that RA, which has a
half-life of less than 1 h in rat plasma in vivo [36], must be present
nearly continuously to maintain normal levels of hepatic Gck
expression.
Acute RA treatment rapidly induced Gck expression in livers of
VAS rats
Next, we examined whether Gck expression responds acutely
to an increase in the circulating level of RA in the VAS state.
For this experiment, rats fed with a standard rodent diet were
treated with a single 25 μg dose of RA administered intra-
venously, and liver tissue was collected after 0 h (vehicle
treatment) and 0.5, 1 and 1.5 h. For comparison, the expression
of Cyp26a1, an RA-4-hydroxylase, rapidly up-regulated by RA
in rat liver [24] was measured (Figure 9B) along with Ubc
(Figure 9A) and Gck mRNAs (Figure 9C). The hepatic expression
of Ubc mRNA was not affected by the RA treatment. Hepatic
Cyp26a1 mRNA was induced rapidly and dramatically after RA
injection, demonstrating the success of RA injection. Hepatic Gck
mRNA was induced concomitantly, and nearly as dramatically,
at 0.5, 1 and 1.5 h after injection respectively. All these results
demonstrated that hepatic Gck expression level can be regulated
directly by retinoids, and especially by RA, in vivo. These
results imply that circulating RA may play an important role
in controlling physiological responses of Gck expression to
nutritional and hormonal stimuli.
DISCUSSION
Liver is well known to contain numerous lipids that release sterols
and retinoids after saponification. Activation of the oxysterol
receptor, LXR, results in the induction of Gck expression in
mouse liver [37]. The results shown here (Figure 4) and presented
by others [38] indicated that this induction may be indirect
as no direct induction of Gck mRNA by T0901317 could be
observed despite robust induction of Srebp-1c mRNA in rat
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Figure 9 Expression levels of Ubc mRNA (A), Cyp26a1 mRNA (B) and Gck
mRNA (C) in the liver of VAS control-fed rats after a single intravenous
injection of 25 μg of RA
Total RNA was isolated from the liver of individual rats at the indicated time points. The results
are presented as −Ct [−Ct = (Ct of 36B4) − (Ct of indicated genes)]. Animal numbers are
2, 2, 3 and 3 for 0, 0.5, 1 and 1.5 h after RA injection respectively (a > c > d; b > d; e > f > g;
all P < 0.03).
hepatocytes, suggesting an SREBP-1c-independent mechanism
mediating LE + insulin effects. The lack of involvement of
SREBP-1c in mediating insulin-induced Gck expression has been
shown in a time course study similar to ours and a knock-
down study using siRNA (small interfering RNA) methodology
[39]. This conclusion is supported by results obtained from mice
bearing Srebp-1c deletion. Their liver Gck expression responded
normally to the cycle of fasting and re-feeding [33].
RA has been shown to induce Gck expression without any
synergistic effect with insulin [16]. Our studies clearly demon-
strated that retinoids synergized with insulin to induce Gck
expression. This discrepancy may be caused by technical differ-
ences, such as culture plates, the medium and the lower concen-
tration of dexamethasone used. The contribution of these factors
to the discrepancy is worth investigating. In addition, RA induced
Gck expression in islets after 24 and 48 h incubation [40]. The
lack of induction in our study may be caused by the short-term
(6 h) incubation, which did not allow us to observe the induction
at later time points. Another explanation is that islets or INS-1
cells may lack the enzymes required to synthesize RA from retinol
or retinal in LE. Further studies are necessary to determine the
mechanism that causes the difference.
Elevation of hepatic VA contents in patients with diabetes
was observed in 1937 [10]. In 1957, it was noted that hepatic
glycogen storage was depleted in VAD rats [11]. The authors
concluded that the depletion of glycogen was caused by the
reduction of glycogenesis from trioses, rather than directly from
glucose. Hepatic glycogen content was dramatically increased
in rats fed with excess VA for only 2 days [41]. Recently, an
elevation of plasma retinol-binding protein 4, a transport protein
for retinol, has been observed in insulin-resistant humans and
animals [42], suggesting the involvement of VA metabolism in
glucose metabolism and insulin resistance. It is possible that the
effects of VA status on the hepatic Gck expression may also play
a role in these observations.
Retinol is reversibly converted into retinal, and retinal is
irreversibly converted into RA [35]. Rat liver microsomes and
cytosol contain enzymes that convert retinol into retinal and re-
tinal into RA. The production of retinal was observed when the
retinol concentration was 10 μM or higher. The production of RA
from retinol only occurred at concentrations of 50 μM or higher
[43]. Our results demonstrated that retinol was effective at 2 μM
or higher. Retinal at 2 μM or higher, which exceeds normally
low levels present in liver, was almost equivalent to RA in its
ability to synergize with insulin. However, RA was effective, and
synergized with insulin, at 0.002 μM. These findings imply that
retinol and retinal most likely play a regulatory role in hepatic Gck
expression when they are converted into the active metabolite, RA,
in situ.
Normally, homoeostasis of plasma and tissue retinol levels is
delicately maintained through a network of enzymes and proteins
involved in the production, storage, transport and catabolism of
retinoids [7,35]. Therefore circulating RA plays a role in sig-
nalling the body’s retinoid status [8]. Indeed, RA produced in the
intestine and circulating through the portal system to the liver has
been observed [6,44]. Our results have demonstrated that a single
treatment with RA, intraperitoneally or intravenously, is sufficient
to induce Gck expression in the livers of VAD and VA-Ad rats.
It seems that RA either synthesized in hepatocytes or delivered
through the circulation can induce Gck expression. It remains
to be determined whether synthesis of RA in hepatocytes, or
extrahepatic organs, followed by export to liver, varies in response
to physiological changes, such as during the cycle of fasting and
re-feeding, and in diabetes.
In recent years, efforts have been devoted to developing
allosteric activators for increasing intracellular GK activity [45].
Our results demonstrate that the pathway mediating the synergy
between retinoids and insulin is a potential drug target. Since GK
is an inducible enzyme at the transcriptional level, manipulation
of its mRNA level is probably more achievable under normal
physiological conditions. In addition, because LE (mainly retinol)
induces Gck expression specifically in hepatocytes, it becomes
possible to induce GK activity in liver without perturbing its level
in pancreatic β-cells. An improved understanding of the whole
pathway may be beneficial for developing treatment strategies for
patients with both types of diabetes.
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